120 related articles for article (PubMed ID: 9496150)
1. Initiation and perpetuation of rat adjuvant arthritis is inhibited by the anti-CD2 monoclonal antibody (mAb) OX34.
Hoffmann JC; Herklotz C; Zeidler H; Bayer B; Rosenthal H; Westermann J
Ann Rheum Dis; 1997 Dec; 56(12):716-22. PubMed ID: 9496150
[TBL] [Abstract][Full Text] [Related]
2. Anti-CD2 (OX34) MoAb treatment of adjuvant arthritic rats: attenuation of established arthritis, selective depletion of CD4+ T cells, and CD2 down-modulation.
Hoffmann JC; Herklotz C; Zeidler H; Bayer B; Westermann J
Clin Exp Immunol; 1997 Oct; 110(1):63-71. PubMed ID: 9353150
[TBL] [Abstract][Full Text] [Related]
3. Suppression of experimental autoimmune encephalomyelitis in Lewis rats by antibodies against CD2.
Jung S; Toyka K; Hartung HP
Eur J Immunol; 1995 May; 25(5):1391-8. PubMed ID: 7539758
[TBL] [Abstract][Full Text] [Related]
4. Effects of the anti-CD2 mAb OX34 on in vivo proliferation.
Hoffmann JC; Herklotz C; Zeitz M; Bayer B; Zeidler H; Westermann J
Ann N Y Acad Sci; 1998 Nov; 859():216-8. PubMed ID: 9928391
[TBL] [Abstract][Full Text] [Related]
5. CTLA4-Ig abrogates the anti-globulin response and prolongs cardiac allograft survival after anti-CD2 treatment.
Stell D; Marshall H; Bradley JA; Bolton EM
Transpl Immunol; 2003; 12(1):1-7. PubMed ID: 14551027
[TBL] [Abstract][Full Text] [Related]
6. Effective treatment of adjuvant arthritis with a stimulatory CD28-specific monoclonal antibody.
Rodríguez-Palmero M; Franch A; Castell M; Pelegrí C; Pérez-Cano FJ; Kleinschnitz C; Stoll G; Hünig T; Castellote C
J Rheumatol; 2006 Jan; 33(1):110-8. PubMed ID: 16395758
[TBL] [Abstract][Full Text] [Related]
7. Anti-CD2 monoclonal antibodies prevent the induction of experimental autoimmune myocarditis.
Inomata T; Watanabe T; Haga M; Hirahara H; Abo T; Okura Y; Hanawa H; Kodama M; Izumi T
Jpn Heart J; 2000 Jul; 41(4):507-17. PubMed ID: 11041101
[TBL] [Abstract][Full Text] [Related]
8. T cell directed immunotherapy of inflammatory demyelination in the peripheral nervous system. Potent suppression of the effector phase of experimental autoimmune neuritis by anti-CD2 antibodies.
Jung S; Toyka K; Hartung HP
Brain; 1996 Aug; 119 ( Pt 4)():1079-90. PubMed ID: 8813272
[TBL] [Abstract][Full Text] [Related]
9. Long-term survival of cardiac allografts in rats treated before and after surgery with monoclonal antibody to CD2.
Hirahara H; Tsuchida M; Watanabe T; Haga M; Matsumoto Y; Abo T; Eguchi S
Transplantation; 1995 Jan; 59(1):85-90. PubMed ID: 7839434
[TBL] [Abstract][Full Text] [Related]
10. Differential clinical efficacy of anti-CD4 monoclonal antibodies in rat adjuvant arthritis is paralleled by differential influence on NF-kappaB binding activity and TNF-alpha secretion of T cells.
Pohlers D; Schmidt-Weber CB; Franch A; Kuhlmann J; Bräuer R; Emmrich F; Kinne RW
Arthritis Res; 2002; 4(3):184-9. PubMed ID: 12010568
[TBL] [Abstract][Full Text] [Related]
11. Treatment of established adjuvant arthritis in rats with monoclonal antibody to CD18 and very late activation antigen-4 integrins suppresses neutrophil and T-lymphocyte migration to the joints and improves clinical disease.
Issekutz AC; Ayer L; Miyasaka M; Issekutz TB
Immunology; 1996 Aug; 88(4):569-76. PubMed ID: 8881759
[TBL] [Abstract][Full Text] [Related]
12. Treatment with an anti-CD4 monoclonal antibody strongly ameliorates established rat adjuvant arthritis.
Pelegrí C; Morante MP; Castellote C; Franch A; Castell M
Clin Exp Immunol; 1996 Feb; 103(2):273-8. PubMed ID: 8565311
[TBL] [Abstract][Full Text] [Related]
13. Administration of a nondepleting anti-CD4 monoclonal antibody (W3/25) prevents adjuvant arthritis, even upon rechallenge: parallel administration of a depleting anti-CD8 monoclonal antibody (OX8) does not modify the effect of W3/25.
Pelegrí C; Paz Morante M; Castellote C; Castell M; Franch A
Cell Immunol; 1995 Oct; 165(2):177-82. PubMed ID: 7553881
[TBL] [Abstract][Full Text] [Related]
14. Anti-CD2 monoclonal antibodies prevent spontaneous and adoptive transfer of diabetes in the BB/Wor rat.
Barlow AK; Like AA
Am J Pathol; 1992 Nov; 141(5):1043-51. PubMed ID: 1359788
[TBL] [Abstract][Full Text] [Related]
15. Prevention of adjuvant arthritis by the W3/25 anti-CD4 monoclonal antibody is associated with a decrease of blood CD4(+)CD45RC(high) T cells.
Pelegrí C; Castell M; Serra M; Rabanal M; Rodríguez-Palmero M; Castellote C; Franch A
Clin Exp Immunol; 2001 Sep; 125(3):470-7. PubMed ID: 11531956
[TBL] [Abstract][Full Text] [Related]
16. Depletion of alpha/beta T cells by a monoclonal antibody against the alpha/beta T cell receptor suppresses established adjuvant arthritis, but not established collagen-induced arthritis in rats.
Yoshino S; Cleland LG
J Exp Med; 1992 Apr; 175(4):907-15. PubMed ID: 1372648
[TBL] [Abstract][Full Text] [Related]
17. Use of anti-platelet-endothelial cell adhesion molecule-1 antibody in the control of disease progression in established collagen-induced arthritis in DBA/1J mice.
Ishikaw J; Okada Y; Bird IN; Jasani B; Spragg JH; Yamada T
Jpn J Pharmacol; 2002 Mar; 88(3):332-40. PubMed ID: 11949889
[TBL] [Abstract][Full Text] [Related]
18. Blood lymphocyte subsets in rats with adjuvant arthritis.
Franch A; Castellote C; Castell M
Ann Rheum Dis; 1994 Jul; 53(7):461-6. PubMed ID: 7944619
[TBL] [Abstract][Full Text] [Related]
19. Differential roles of VLA-4(CD49d/CD29) and LFA-1(CD11a/CD18) integrins and E- and P-selectin during developing and established active or adoptively transferred adjuvant arthritis in the rat.
Issekutz AC; Nakazato S; Issekutz TB
Immunol Cell Biol; 2003 Oct; 81(5):397-408. PubMed ID: 12969328
[TBL] [Abstract][Full Text] [Related]
20. Anti-neutrophil monoclonal antibody therapy inhibits the development of adjuvant arthritis.
Santos LL; Morand EF; Hutchinson P; Boyce NW; Holdsworth SR
Clin Exp Immunol; 1997 Feb; 107(2):248-53. PubMed ID: 9030860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
